< Return to trials
Hypertriglyceridemia
Overview
Lillestol Research has trial experience in the hypertriglyceridemia indication/diagnosis. Our research patient database also presents several hundred patients with this diagnosis that would be interested in clinical trial participation.
Spotlight Trial(s)
This is an investigational product, placebo-controlled trial evaluating cardiovascular effects in hypertriglyceridemic patients with cardiovascular disease or cardiovascular risk factors. Lillestol Research is a worldwide top enroller on this trial. Our site has been able to successfully meet and far exceed the sponsor’s enrollment expectation randomizing 92 patients to the trial. Recruitment is ongoing.